| Financial Year |
March 31 2023 |
| Monetary Funds |
573,927,259.84 |
| Held-for-trading Financial Assets |
1,122,998,094.00 |
| Notes Receivable |
215,942,584.48 |
| Accounts Receivable |
593,576,217.01 |
| Advances to Suppliers |
306,582,760.18 |
| Other Receivables |
15,771,762.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
858,341,010.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,173,622.42 |
| Total Current Assets |
3,785,899,568.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
289,951.42 |
| Long-term Equity Investment |
501,025.14 |
| Investment Properties |
38,724,094.49 |
| Fixed Assetes |
1,800,804,796.73 |
| Under-construction Projects |
350,013,612.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
188,806,286.17 |
| R&D expenses |
-- |
| Goodwill |
1,413,349.20 |
| Long-Term Deferred and Prepaid Expenses |
53,544,159.84 |
| Deferred Income Tax Assets |
22,909,802.76 |
| Other Non-Current Assets |
19,122,547.87 |
| Sub-Total of Non-Current Assets |
2,488,550,115.61 |
| Total Assets |
6,274,449,684.57 |
| Short-Term Loans |
437,603,068.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
29,400,000.00 |
| Accounts Payable |
306,066,958.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
74,263,062.81 |
| Taxes Payable |
35,544,150.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,476,192.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
301,928,124.25 |
| Other Current Liabilities |
246,627,516.84 |
| Sub-Total of Current Liabilities |
1,638,124,951.99 |
| Long-term Loans |
344,673,628.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,736,065.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
114,130,931.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
536,531,504.66 |
| Total Liabilities |
2,174,656,456.65 |
| Paid-In Capital(Or Share Stock) |
323,700,000.00 |
| Capital Surplus |
963,444,540.10 |
| Surplus Reserve |
170,204,832.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,544,552,557.98 |
| Minority Stockholder's Interest |
53,273,817.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,046,519,410.25 |
| Owner's Equity（Stockholder's Equity） |
4,099,793,227.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,274,449,684.57 |
